What Abliance does

Abliance (ABLIANCE SAS) is a French antibody manufacturer and contract service provider headquartered in Compiègne, France, operating as a subsidiary of BIOLABO GROUP. The company traces its lineage to BIOSYS (founded 1981), which became P.A.R.I.S SA SCOP in 2000 and was reorganized into ABLIANCE SAS following a 2014 asset acquisition. It serves 300+ clients worldwide across in vitro diagnostics, pharmaceutical, research, clinical research, and agro-food/environmental end markets. Its customer base spans major healthcare enterprises and biotechnology startups requiring validated antibodies and regulatory-grade documentation.

The company's product and service portfolio spans the full antibody lifecycle. On the products side, Abliance maintains a catalog of secondary polyclonal antibodies covering more than a dozen host species (human, mouse, rabbit, goat, bovine, horse, dog, guinea pig, hamster, sheep, swine, rat) offered as globulins, affinity-purified antibodies, and Fab or F(ab')2 fragments, with multiple label formats including HRP, AP, FITC, biotin, BGal, and glucose oxidase. On the services side, it offers custom monoclonal antibody development (4–12 month projects covering immunogen preparation, fusion, screening, cloning, and cell bank creation), in vitro antibody production from hybridomas and eukaryotic recombinant cell lines (CHO, NSO, BHK21) at batch scales from milligrams to over 100 grams, secure cell banking with dual-site geographic redundancy (Compiègne and Amiens via Biobanque de Picardie), and downstream purification, conjugation, and fragmentation services. The specialized dialysis production system is positioned as a proprietary differentiator delivering high antibody concentration with simplified purification. Since July 1, 2015, Abliance has also been the exclusive distributor of BIOLABO reagents in France and export retailer for orders below €2,000.

The business model is B2B sales-led with quote-based project pricing for custom development and production work, per-milligram pricing for antibody output, quarterly recurring storage fees for cell banking, and catalog/bulk unit pricing for secondary antibodies and BIOLABO reagents. Pricing is not publicly listed; an example cell banking contract for 3 cell lines / 60 tubes is approximately €78 per month excluding admission fee, and F(ab')2 fragments are listed at €215 per 2 mg/1 ml unit. The company is ISO 9001 certified and holds French Ministry of Research (CIR) approval. Distribution is direct in France with export support through the same sales administration team. Marketing is primarily through the company website, direct inquiry, and industry publications.

Name

Abliance

Legal name

ABLIANCE SAS

Website

https://abliance.com

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

1–10 employees

Short description

Abliance is a French antibody manufacturer offering a catalog of secondary polyclonal antibodies plus custom monoclonal antibody development, in vitro production, dual-site cell banking, and purification/conjugation services to diagnostic, pharmaceutical, research, and biotech clients in France and worldwide.

Ownership category

akta.pro rank

Product category

Antibody Manufacturing and Contract Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• Antibody manufacturing
• Monoclonal antibody services
• Polyclonal antibody production
• Cell banking services
• Antibody conjugation services

Headquarters

HQ city

Compiègne

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. Custom Antibody Development Services: Project-based monoclonal antibody development services. Each project is quoted individually based on technical requirements. Projects last 4-12 months with steps including specification definition, immunogen preparation, immunizations, fusion, screening, cloning, pilot production, and final validation.
2. Monoclonal Antibody Production: Production of antibody batches from milligrams to 100+ grams using various systems including dialysis, batch, roller bottles, bags, fermenters, and spinner flasks. Pricing committed per mg of purified or unpurified antibodies after assessment phase.
3. Cell Banking Services: Secure cell line storage with quarterly billing based on number of cell lines and total tubes. Includes optional services for viability controls, productivity controls, bank reconstitution, and antibody production.
4. Secondary Antibody Products: Catalog of detection reagents including secondary polyclonal antibodies sold in bulk. Products available as globulins, affinity purified antibodies, Fab and F(ab')2 fragments with various conjugations.
5. BIOLABO Reagent Distribution: Exclusive distributor of BIOLABO reagents in France and retailer for export. Handles all orders for France regardless of amount, and orders below 2000€ for overseas markets.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

ABLIANCE develops, produces, and distributes custom and catalog antibodies for healthcare, diagnostics, pharmaceutical, and research customers. Core offerings include monoclonal antibody development services (hybridoma-based, 4-12 month projects), monoclonal antibody production at mg to 100+ gram scales, dual-site cell banking for client cell lines, and antibody purification, conjugation, and fragmentation services. The company also sells a catalog of secondary polyclonal antibodies and is the exclusive French distributor of BIOLABO reagents.

Product overview

Abliance is a French antibody manufacturer offering a portfolio of secondary polyclonal antibodies and contract research/production services. The core product line consists of catalog secondary antibodies (anti-human, anti-mouse, anti-rabbit, anti-goat, anti-bovine, anti-horse, anti-dog, anti-guinea pig, anti-hamster, anti-sheep, anti-swine, anti-rat) available as globulins, affinity purified antibodies, Fab fragments, and F(ab')2 fragments, with various labels including HRP, AP, FITC, Biotin, BGal, and Glucose oxidase. Service offerings include monoclonal antibody development (4-12 month projects), monoclonal antibody production (batch sizes from mg to 100g+ using dialysis and traditional systems), cell banking at dual geographically-separated sites, and antibody purification/conjugation/fragmentation. Abliance also resells BIOLABO reagents as an exclusive French distributor.

Differentiator

Problem solved

Functional benefit

Products and services

• Secondary Polyclonal Antibodies (Catalog) Catalog of secondary polyclonal antibodies for immunodetection techniques including ELISA, Western Blot, immunohistochemistry, immunocytochemistry, and flow cytometry. Available for 12 species (human, mouse, rabbit, goat, bovine, horse, dog, guinea pig, hamster, sheep, swine, rat) with various labels (HRP, AP, FITC, Biotin, BGal, Glucose oxidase) and forms (globulins, affinity purified antibodies, Fab and F(ab')2 fragments). ISO 9001:2008 manufactured for anti-human range. Customers include research laboratories, IVD manufacturers, and pharma.
• Monoclonal Antibody Development Services Full-service custom monoclonal antibody development from antigen preparation through immunogen preparation, immunizations, fusion, screening, cloning, and pilot production. Projects include specification definition and step-by-step validation with confidential project management. Delivery of 2-5 cell bank clones per development project on average. Timelines of 4-12 months per project. Targets healthcare, IVD, pharmaceutical, and biotech customers needing custom antibody creation.
• Monoclonal Antibody Production Services In vitro production of monoclonal antibodies from hybridomas and eukaryotic recombinant cell lines (CHO, NSO, BHK21). Production systems include specialized dialysis technology, batch, roller bottles, bags, fermenters, and spinner flasks. Batch sizes from milligrams to over 100 grams. Pricing committed per mg of purified or unpurified antibodies after an assessment phase. Includes dialysis production technology achieving ascites-comparable antibody concentrations with simplified purification. For IVD, pharma, biotech, and research customers.
• Cell Banking and Cell Line Maintenance Services Secure storage and management of antibody-producing cell lines with dual-site geographic storage at ABLIANCE in Compiègne and Biobanque de Picardie in Amiens for backup and business continuity. Includes viability controls, productivity controls, bank reconstitution, mycoplasma testing and removal, and optional antibody production. Subscription billing with quarterly payment based on number of cell lines and total tubes (example: 3 cell lines with 20 tubes each costs ~78 EUR/month excluding admission fee). For biotech, pharma, and research customers with proprietary cell lines requiring secure long-term storage.
• Purification, Conjugation, and Fragmentation Services Antibody purification via gel filtration, ion exchange, protein A/G, and immunoaffinity methods. Conjugation (labeling) services include enzymatic (peroxidase, alkaline phosphatase, glucose oxidase, beta-galactosidase), fluorescent (FITC, Cyanine, Phycoerythrin), biotinylations, and custom protocol development. Fragmentation (F(ab')2 and Fab) services through enzymatic digestion for reduced non-specific binding and improved tissue penetration. For IVD manufacturers, pharma, biotech, and research customers.
• BIOLABO Reagents Distribution Exclusive distribution of BIOLABO reagents in France and export retail for orders below 2000 EUR. Product range includes biochemistry reagents, TIA reagents, coagulation reagents, calibrators, controls, and slide tests. Sales administration team handles all French orders regardless of amount.

Quantifiable outcome

• Production capacity from milligrams to 100+ gram batches
• +2 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• P.A.R.I.S SA SCOPcoreOthers · 20 March 2014P.A.R.I.S SA SCOP, which had been serving clients since 2000, announced the acquisition of its assets by ABLIANCE SAS. ABLIANCE assumed all commercial proposals and agreements initially signed by P.A.R.I.S.
• BIOLABO GROUPcoreOthersABLIANCE is a company of BIOLABO GROUP. On July 1, 2015, ABLIANCE became the exclusive distributor of BIOLABO reagents in France and retailer for export sales below €2,000.
• Biobanque de PicardiecoreStrategic or Co-development PartnerGeographic backup storage partner for cell banking services. Cell lines are stored on two geographically distinct sites: ABLIANCE in Compiègne and Biobanque de Picardie in Amiens, allowing recovery of materials if one site is destroyed.
• BPC BioSedminorOthersRelated company within the BIOLABO GROUP ecosystem. Website redirect available to BPC BioSed website.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• GenScript: Global custom antibody service provider offering monoclonal and polyclonal antibody development, hybridoma services, and protein engineering. Competes directly for biotech startup and pharma custom antibody projects.
• Jackson ImmunoResearch: Specialist manufacturer of secondary antibodies and immunodetection reagents with extensive catalog across species. Highly comparable secondary polyclonal antibody catalog business.
• Eurogentec (Kaneka Eurogentec): Belgian contract research organization offering custom antibody production, peptide synthesis, and molecular biology services. Comparable European CRO/CDMO focused on antibody services for diagnostics and research.
• BioGenes: German contract service provider specializing in custom antibody development, monoclonal and polyclonal antibody production, and immunoassay development. Comparable European niche CRO for antibody services.
• Rockland Immunochemicals: US-based antibody manufacturer offering catalog secondary antibodies, custom polyclonal services, and conjugation services. Directly competes in catalog secondary antibodies and custom antibody production.
• ProteoGenix: French custom antibody development and production service company offering monoclonal and polyclonal antibody services, hybridoma development, and protein production. Closest direct competitor based on geography, service portfolio, and customer segment overlap.

Emerging players

• Synbio Technologies: Custom antibody and protein services company with hybridoma and recombinant antibody offerings. Comparable emerging competitor in custom antibody services for research and diagnostic applications.

Broad incumbents

• Cell Signaling Technology: Leading US-based provider of antibodies for signal transduction research with broad catalog. Competes primarily in catalog antibody space for research lab customers.
• Abcam (Danaher): Global leader in catalog antibodies and reagents for research, with growing custom antibody offerings post-Danaher acquisition. Competes for secondary antibody customers but at vastly larger scale.
• Thermo Fisher Scientific (Antibody Business): Major life sciences tools company offering catalog antibodies (Invitrogen, Thermo Scientific brands) and custom antibody services through its bioscience division. Broad incumbent with overlapping catalog and custom offerings.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/abliance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Abliance